C4 Therapeutics Entered into an Exclusive License Agreement with Betta to Develop and Commercialize CFT8919 for Non-Small Cell Lun...
Shots: C4T will receive $35M incl. $10M up front & $25M one-time equity invest...
Shots: C4T will receive $35M incl. $10M up front & $25M one-time equity invest...
Shots: InDex will receive $10M up front for the exclusive rights to commercialize...
Shots: Stealth will receive up front, development, regulatory & commercial mil...
Shots: Sun Pharma to get an exclusive right to commercialize Nidlegy (developed by...
Shots: The companies collaborated to discover & develop novel therapies for pa...
Shots: Akebia will receive $10M up front, ~$100M in commercial milestones for righ...
Incisive News in 3 Shots.